Patent delisted for Astrazeneca Ab drug BYDUREON
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. […]
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Patent Expiration
Patent delisted for Astrazeneca Ab drug BYDUREON PEN
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Patent delisted for Acorda drug AMPYRA
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It
Patent delisted for Abbvie drug KALETRA
Annual Drug Patent Expirations for KALETRA Kaletra is a drug marketed by Abbvie and is included in three NDAs. It
Patent delisted for Daiichi Sankyo drug BENICAR
Annual Drug Patent Expirations for BENICAR Benicar is a drug marketed by Daiichi Sankyo and is included in two NDAs.
Patent delisted for Helsinn Hlthcare drug ALOXI
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs.
Patent delisted for Daiichi Sankyo drug BENICAR HCT
Annual Drug Patent Expirations for BENICAR+HCT Benicar Hct is a drug marketed by Daiichi Sankyo and is included in one
Patent delisted for Daiichi Sankyo drug BENICAR HCT Read Post »
Patent delisted for Teva Pharms drug COPAXONE
Annual Drug Patent Expirations for COPAXONE Copaxone is a drug marketed by Teva Pharms Usa and is included in one
Patent delisted for IMPAX drug ADRENACLICK
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It
